9
Views
7
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Transformation of NIH 3T3 Cells by Overexpression of the Normal Coding Sequence of the Rat neu Gene

, , &
Pages 3247-3252 | Received 27 Nov 1989, Accepted 13 Feb 1990, Published online: 01 Apr 2023

Literature Cited

  • Akiyama, T., C. Sudo, H. Ogawara, K. Toyoshima, and T. Yamamoto. 1986. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644–1646.
  • Bargmann, C. I., M. C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of pl85. Cell 45:649–657.
  • Bargmann, C. I., and R. A. Weinberg. 1988. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J. 7:2043–2052.
  • Bargmann, C. I., and R. A. Weinberg. 1988. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc. Natl. Acad. Sci. USA 85:5394–5398.
  • Coussens, L., T. L. Yang-Feng, Y. C. Liao, E. Chen, A. Gray, J. McGrath, P. H. Seeburg, T. A. Libermann, J. Schlessinger, U. Francke, A. Levinson, and A. Ullrich. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–1139.
  • Di Fiore, P. P., J. H. Pierce, M. H. Kraus, O. Segatto, C. R. King, and S. A. Aaronson. 1987. erbB-2 is a potent oncogene with overexpressed in NIH/3T3 cells. Science 237:178–182.
  • Di Fiore, P. P., O. Segatto, F. Lonardo, F. Fazioli, J. H. Pierce, and S. A. Aaronson. 1990. The carboxy-terminal domains of erbB-2 and epiderminal growth factor receptor exert different regulatory effects on intrinsic receptor kinase function and transforming activity. Mol. Cell. Biol. 10:2749–2756.
  • Fukushige, S., K. Matsubara, M. Yoshida, M. Sasaki, T. Suzuki, K. Semba, K. Toyoshima, and T. Yamamoto. 1986. Localization of a novel \-erbB related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol. Cell. Biol. 6:955–958.
  • Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467.
  • Hudziak, R. M., J. Schlessinger, and A. Ullrich. 1987. Increased expression of the putative growth factor receptor pl85HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 84:7159–7163.
  • Hung, M. C., A. L. Schechter, P. Y. Chevray, D. F. Stern, and R. A. Weinberg. 1986. Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc. Natl. Acad. Sci. USA 83:261–264.
  • King, C. R., M. H. Kraus, and S. A. Aaronson. 1985. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229:974–976.
  • Kraus, M. H., N. C. Popescu, S. C. Amsbaugh, and C. R. King. 1987. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6:605–610.
  • Mulligan, R. C., and P. Berg. 1981. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA 78:2072–2076.
  • Padhy, L. C., C. Shih, D. Cowing, R. Finkelstein, and R. A. Weinberg. 1982. Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 28:865–871.
  • Pang, D. T., B. R. Sharma, and J. A. Shafer. 1985. Purification of the catalytically active phosphorylated form of insulin receptor kinase by affinity chromatography with O-phosphotyrosyl-binding antibodies. Arch. Biochem. Biophys. 242:176–186.
  • Segatto, O., C. R. King, J. H. Pierce, P. P. Di Fiore, and S. A. Aaronson. 1988. Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Mol. Cell. Biol. 8:5570–5574.
  • Semba, K., N. Kamata, K. Toyoshima, and T. Yamamoto. 1985. A verbB-related proto-oncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA 82:6497–6501.
  • Shih, C., L. C. Padhy, M. Murray, and R. A. Weinberg. 1981. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature (London) 290:261–264.
  • Shinnick, T. M., R. A. Lerner, and J. G. Sutcliffe. 1981. Nucleotide sequence of Moloney murine leukaemia virus. Nature (London) 293:543–548.
  • Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182.
  • Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press. 1988. Studies of the HER-2/Ineu proto-oncogene in human breast and ovarian cancer. Science 244:707–712.
  • Stern, D. F., P. A. Heffernan, and R. A. Weinberg. 1986. pl85, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol. Cell. Biol. 6:1729–1740.
  • Stern, D. F., M. P. Kamps, and H. Cao. 1988. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo. Mol. Cell. Biol. 8:3969–3973.
  • Wigler, M., S. Silverstein, L. S. Lee, A. Pellicer, Y.-C. Cheng, and R. Axel. 1977. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11:223–232.
  • Yarden, Y., and R. A. Weinberg. 1989. Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene. Proc. Natl. Acad. Sci. USA 86:3179–3183.
  • Yokota, J., T. Yamamoto, K. Toyoshima, M. Terada, T. Sugimura, H. Battifora, and M. J. Cline. 1986. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet i:765–767.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.